Price Forecast:

Bullish Case: Upcoming product launches and continued strong demand for minimally invasive procedures may elevate INMD's price significantly. Historical trends indicate potential growth if selling pressure eases and market confidence rebounds.

Bearish Case: Persistent legal challenges and macroeconomic headwinds could suppress consumer spending, dragging INMD's stock price lower, especially if demand declines and implied volatility spikes consistently over the next few months.

Potential Outcomes:

• Revenue growth of 20% due to strong demand (60% chance)
• Economic downturn leads to 10% revenue drop (30% chance)
• Shareholder buybacks boost EPS (10% chance)

Trading Oracle: Consider executing a bullish debit spread by buying the INMD 01/17/2025 $20 call and selling the $22 call. With rising volatility in the current term structure, this captures upside while limiting risks. Projected high reward/risk ratio; target a 75% probability of profit with a potential return of 45%.

November 24, 2024